In the race to develop new and better vaccines and boosters to block COVID-19, scientists…
dcorriganAugust 13, 2021
Eliem Therapeutics joined the ranks of publicly traded companies from Washington state, pricing 6.4 million shares…
dcorriganAugust 11, 2021
Kineta Inc, through its subsidiary Kineta Chronic Pain LLC, announced today that the company has…
dcorriganAugust 11, 2021
Targeted therapies have transformed outcomes for lung cancer patients. After reduced smoking rates, drugs that…
dcorriganAugust 11, 2021
Seagen Inc., a world leader and pioneer in antibody-drug conjugate (ADC) therapies, and RemeGen Co.,…
dcorriganAugust 10, 2021
Sonoma Biotherapeutics, a life sciences company developing treatments for autoimmune diseases, announced this week it raised $265…
dcorriganAugust 10, 2021
Three epidemic or pandemic coronaviruses – SARS-CoV, MERS-CoV, & SARS-CoV-2 – have spilled over from…
dcorriganAugust 9, 2021
In the wake of findings that COVID-19 virus variants are more likely to spring from…
dcorriganAugust 6, 2021
Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the…
dcorriganAugust 6, 2021
